1,689
Views
6
CrossRef citations to date
0
Altmetric
Clinical Study

Prophylactic Use of Omeprazole Associated with a Reduced Risk of Peptic Ulcer Disease Among Maintenance Hemodialysis Patients

, , , , , , , & show all
Pages 323-328 | Received 18 Nov 2010, Accepted 27 Jan 2011, Published online: 14 Mar 2011

REFERENCES

  • Toke AB. GI bleeding risk in patients undergoing dialysis. Gastrointest Endosc. 2010;71:50–52.
  • Holden RM, Harman GJ, Wang M, Holland D, Day AG. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:105–110.
  • Cheung J, Yu A, LaBossiere J, Zhu Q, Fedorak RN. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010;71:44–49.
  • Tseng GY, Lin HJ, Fang CT, . Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: A 2-year study. Aliment Pharmacol Ther. 2007; 26:925–933.
  • Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75:96–103.
  • Nakajima F, Sakaguchi M, Amemoto K, Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol. 2002;22:468–472.
  • Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374:1449–1461.
  • Chan FK, Hung LC, Suen BY, Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002;347:2104–2110.
  • Chan FK, Ching JY, Hung LC, Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238–244.
  • Yeomans N, Lanas A, Labenz J, Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol. 2008;103:2465–2473.
  • Howden CW, Payton CD, Meredith PA, Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure. Eur J Clin Pharmacol. 1985;28:637–640.
  • Yen TH, Lin JL, Lin-Tan DT, Hsu CW, Weng CH, Chen YH. Spectrum of corrosive esophageal injury after intentional paraquat ingestion. Am J Emerg Med. 2010; 28:728–733.
  • Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal hemorrhage. Gut. 1996;38:316–321.
  • Tseng GY, Lin HJ. Aspirin prescription and outcomes in hemodialysis patients. Am J Kidney Dis. 2008;51:1070–1071.
  • Tseng GY, Lin HJ. Factors aside from Helicobacter pylori play an important role in the occurrence of peptic ulcer in dialysis patients. Kidney Int. 2009;75:1114–1115.
  • Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI. Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time. Kidney Int. 2005;68:2323–2330.
  • Yoshikawa I, Nagato M, Yamasaki M, Kume K, Otsuki M. Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World J Gastroenterol. 2009; 15:4794–4798.
  • Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947–2953.
  • Kirkpantur A, Altun B, Arici M, Turgan C. Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance hemodialysis patients. Int J Clin Pract. 2009;63:261–268.
  • Toussaint ND, Elder GJ, Kerr PG. A rational guide to reducing fracture risk in dialysis patients. Semin Dial. 2010; 23:43–54.
  • K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2003;42(4 Suppl. 3): S1–S201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.